The Future of Knee Injury Management: Insights from LT Health Conference 2025

Table of Contents

Genourob's Innovations Once Again Shine at the LT Health Conference 2025

This year, Genourob, represented by Abili, continued to make an impact at the LT Health Conference held in Kaunas, Lithuania. The event, titled “We Are Not Ready for the Joint Replacement! 2025, brought together leading experts and professionals in the field of orthopedics and rehabilitation. One of the highlights of this year’s conference was the insightful presentation delivered by Dr. Henri Robert, Ph.D., a key collaborator of Genourob.

The LT Health Conference is an essential annual event where researchers, clinicians, and medical technology developers discuss the latest advancements in musculoskeletal health. It focuses on innovative solutions that aim to prevent or delay joint replacements, offering alternatives that improve patients’ quality of life without resorting to invasive surgical procedures.

Genourob, through its collaboration with Abili, has been at the forefront of developing cutting-edge knee assessment tools that assist in both diagnosing injuries and guiding treatment plans. The company’s participation in this event underscores its dedication to advancing orthopedic care through science and technology.

Dr. Henri Robert’s Presentation

Photo of Dr Henri Robert
Dr Henri Robert, Orthopaedic Surgeon

Dr. Henri Robert presented his talk from 16:20 to 16:30, focusing on the crucial role of biomechanical analysis in knee injury management. His intervention, titled “Biomechanical Analysis of the Various Components of the Medial Plane of the Knee Using the Dyneelax Laximeter: Therapeutic Conclusions for the Management of Injuries,” shed light on the advanced diagnostic capabilities offered by the Dyneelax system.

During his presentation, Dr. Robert emphasized how biomechanical evaluations are essential for understanding the stability and function of the knee joint. By using objective measurement tools like the Dyneelax laximeter, clinicians can obtain accurate, repeatable data that enhances diagnostic precision and helps tailor treatment strategies.

The Dyneelax Laximeter: A Game-Changer

The Dyneelax laximeter allows for precise, objective, and reproducible assessments of knee ligament stability, particularly in the medial plane. By analyzing translation and rotation movements, it provides valuable data that can guide treatment decisions for knee injuries.

One of the key advantages of Dyneelax is its ability to quantify both translational and rotational knee laxity. Unlike traditional manual tests, which can be subjective, Dyneelax offers standardized, automated measurements that remove variability and improve reliability. This technology is particularly beneficial for:

  • Early diagnosis of ligament injuries

  • Preoperative planning for knee surgeries

  • Postoperative rehabilitation monitoring

  • Long-term follow-up of ligament healing

Dr. Robert’s presentation emphasized how these biomechanical insights contribute to improved therapeutic strategies and better patient outcomes. By using the Dyneelax laximeter, clinicians can make data-driven decisionsthat help prevent unnecessary surgeries and optimize rehabilitation protocols.

Knee Ligament Arthrometer Device, acl injury diagnosis, ACL Injury Diagnosis Tool
Dyneelax Robotic Arthrometer

The Importance of LT Health Conference

The LT Health Conference continues to be an important platform for innovation in musculoskeletal health, highlighting cutting-edge technologies that enhance diagnosis and rehabilitation. With the increasing burden of joint injuries and osteoarthritis, events like this foster collaborations that can drive the development of effective non-surgical treatments and improve long-term patient care.

One of the main themes of this year’s event was the importance of preserving joint integrity through early intervention and personalized treatment approaches. This aligns perfectly with Genourob’s mission, which is to provide clinicians with advanced tools that offer precise and actionable biomechanical data.

By being part of LT Health 2025, Genourob and Abili have reinforced their position as leaders in the field of knee ligament assessment. Their innovative solutions are not only enhancing clinical practice but are also shaping the future of non-invasive orthopedic care.

We are not ready for joint replacement 2025

Looking Ahead

As knee injuries and joint disorders become more prevalent, the need for advanced diagnostic solutions continues to grow. Genourob remains committed to developing state-of-the-art medical technologies that help clinicians provide personalized and effective treatments.

The discussions and presentations at LT Health 2025 have highlighted the importance of integrating biomechanics into orthopedic care. Moving forward, Genourob and Abili will continue to work closely with healthcare professionals to promote evidence-based practices and ensure that patients receive the best possible care.

For more details on the conference, visit LT Health.

Want to keep up with our blog?

Get our most valuable tips right inside your inbox!

Related Posts

Receive the latest news

Subscribe To Our Weekly Newsletter

Get notified about new articles